| Ident. | Authors (with country if any) | Title |
|---|
| 000B40 (2013) |
Catherine A. Goubko [Canada] ; Ajoy Basak [Canada] ; Swapan Majumdar [Canada] ; Harold Jarrell [Canada] ; Nam Huan Khieu [Canada] ; Xudong Cao [Canada] | Comparative analysis of photocaged RGDS peptides for cell patterning |
| 000B42 (2013) |
Li-Hua Li [Taïwan] ; Hao-Jen Hsu [Taïwan] ; Wolfgang B. Fischer [Taïwan] | Assembling viral channel forming proteins: Vpu from HIV‐1 |
| 000B43 (2013) |
Tze-Hsiang Chien [Taïwan] ; Ya-Ling Chiang [Taïwan] ; Chin-Pei Chen [Taïwan] ; Petra Henklein [Allemagne] ; Karen H Nel [Allemagne] ; Ing-Shouh Hwang [Taïwan] ; Dieter Willbold [Allemagne] ; Wolfgang B. Fischer [Taïwan] | Assembling an ion channel: ORF 3a from SARS‐CoV |
| 000D33 (2010) |
Jianfeng Guothese Author Made An Equal Contribution To This Work. [Irlande (pays)] ; Karen A. Fisher [Irlande (pays)] ; Raphael Darcy [Irlande (pays)] ; John F. Cryan [Irlande (pays)] ; Caitriona Odriscoll [Irlande (pays)] | Therapeutic targeting in the silent era: advances in non-viral siRNA delivery |
| 000D45 (2010) |
Jun Liu [République populaire de Chine, États-Unis] ; Min Shi [États-Unis] ; Zhen Hong [République populaire de Chine] ; Jianpeng Zhang [États-Unis] ; Joshua Bradner [États-Unis] ; Thomas Quinn [États-Unis] ; Richard P. Beyer [États-Unis] ; Patrick L. Mcgeer [Canada] ; Shengdi Chen [République populaire de Chine] ; Jing Zhang [États-Unis] | Identification of ciliary neurotrophic factor receptor α as a mediator of neurotoxicity induced by α‐synuclein |
| 000D92 (2009) |
| Short Communication |
| 000E57 (2008) |
| Poster Presentations |
| 000E72 (2008) |
| Abstracts Thirty‐Seventh Annual Meeting American College of Clinical Pharmacology September 14–16, 2008 Philadelphia, Pennsylvania |
| 000F03 (2007) |
| Preview: ChemBioChem 9/2007 |
| 000F09 (2007) |
| Index: ChemBioChem 2007 |
| 000F11 (2007) |
| Graphical Abstract: ChemBioChem 9/2007 |
| 000F21 (2007) |
| ACVIM Forum Abstracts |
| 000F24 (2007) |
Ajoy Basak ; Abhijit Mitra [États-Unis] ; Sarmistha Basak ; Carolyn Pasko ; Michel Chrétien ; Pamela Seaton [États-Unis] | A Fluorogenic Peptide Containing the Processing Site of Human SARS Corona Virus S‐Protein: Kinetic Evaluation and NMR Structure Elucidation |
| 000F56 (2006) |
Yasuko Tsunetsugu-Yokota [Japon] ; Kazuo Ohnishi [Japon] ; Toshitada Takemori [Japon] | Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine |
| 000F60 (2006) |
| Poster Presentation Abstracts |
| 000F66 (2006) |
Kristian Flikka [Norvège] ; Lennart Martens [Belgique] ; Joël Vandekerckhove [Belgique] ; Kris Gevaert [Belgique] ; Ingvar Eidhammer [Norvège] | Improving the reliability and throughput of mass spectrometry‐based proteomics by spectrum quality filtering |
| 000F79 (2006) |
Brigitte Bauvois [France] ; Daniel Dauzonne [France] | Aminopeptidase‐N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects |
| 001042 (2004) |
Harald Von Boehmer [États-Unis] ; Michel C. Nussenzweig [États-Unis] | The manipulation of immunity |
| 001070 (2004) |
| Abstracts |
| 001089 (2003) |
A. Bukowska ; J. Tadje ; M. Arndt ; C. Wolke ; T. K Hne ; J. Bartsch ; J. Faust ; K. Neubert ; Y. Hashimoto ; U. Lendeckel | Transcriptional Regulation of Cytosol and Membrane Alanyl-Aminopeptidase in Human TCell Subsets |
| 001092 (2003) |
| Research Abstract Program of the 21st Annual ACVIM Forum Charlotte, NC, June 4–7, 2003 |
| 001115 (2002) |
Kanchan Anand [Allemagne] ; Gottfried J. Palm [Allemagne] ; Jeroen R. Mesters [Allemagne] ; Stuart G. Siddell [Allemagne] ; John Ziebuhr [Allemagne] ; Rolf Hilgenfeld [Allemagne] | Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α‐helical domain |
| 001131 (2001) |
Bert A. Hart [Pays-Bas] ; Herbert P. M Brok [Pays-Bas] ; Sandra Amor [Pays-Bas] ; Ronald E. Bontrop [Pays-Bas] | The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels |
| 001160 (2000) |
Per Klemm [Danemark] ; Mark A. Schembri [Danemark] | Fimbriae assisted bacterial surface display of heterologous peptides |
| 001172 (1999) |
Douglas S. Zatechka Jr. [États-Unis] ; Nagendra R. Hegde [États-Unis] ; Kandasamy Hariharan [États-Unis] ; S. Srikumaran [États-Unis] | Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1 |
| 001174 (1999) |
Dhammika S. Jayawardene [États-Unis] ; Chhabil Dass [États-Unis] | The effect of N-terminal acetylation and the inhibition activity of acetylated enkephalins on the aminopeptidase M-catalyzed hydrolysis of enkephalins☆ |
| 001196 (1998) |
Per Johan Klasse [Royaume-Uni] ; Romke Bron [Royaume-Uni] ; Mark Marsh [Royaume-Uni] | Mechanisms of enveloped virus entry into animal cells |
| 001202 (1998) |
John Lubinski [États-Unis] ; Thandavarayan Nagashunmugam [États-Unis] ; Harvey M. Friedman [États-Unis] | Viral interference with antibody and complement |
| 001264 (1995) |
Kai W. Wucherpfennig [États-Unis] ; Jack L. Strominger [États-Unis] | Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein |
| 001280 (1995) |
M. L. Akyürek [Suède] ; A. Wanders [Suède] ; M. Aurivillius [Suède] ; E. Larsson [Suède] ; K. Funa [Suède] ; B. C. Fellström [Suède] | Effects of angiopeptin on transplant arteriosclerosis in the rat |
| 001290 (1994) |
Gerald J. Chader [États-Unis] | Retinal degenerations of hereditary, viral and autoimmune origins: Studies on opsin and IRBP |
| 001295 (1994) |
Benjamin M. Segal [États-Unis] ; Cedric S. Raine [États-Unis] ; Dale E. Mcfarlin [États-Unis] ; Rhonda R. Voskuhl [États-Unis] ; Henry F. Mcfarland [États-Unis] | Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination |
| 001317 (1993) |
| Vaccine containing cattle papilloma virus-2 and/or cattle papilloma virus-4 L2 protein; for use as recombinant vaccine or in tumour therapy |
| 001321 (1993) |
| Retrovirus-mediated recombinant fusion protein preparation; vector with Rous-sarcoma virus gag gene myristylation site for recombinant vaccine production in CV-1, COS-1, NIH3T3 or turkey embryo fibroblast cell culture as membranous particle |
| 001323 (1993) |
| Peptides corresponding to regions of HPV-16 E1 and E2 proteins: human recombinant papilloma virus-16 E1 and E2 protein sero-reactive region and monoclonal antibody useful in cervix carcinoma vaccine, diagnosis |
| 001324 (1993) |
| Patent bibliography |
| 001326 (1993) |
| New nucleic acid encoding E2 protein of canine corona virus; dog corona virus recombinant E2 protein production; may be used in recombinant vaccine production |
| 001327 (1993) |
| Induction of immunological response to mammal pathogen; rabies virus, cattle leukaemia virus, cat leukaemia virus or herpes simplex virus antigen gene cloning in an avipox virus vector for use as a recombinant vaccine |
| 001332 (1993) |
| Workshop P: Neuroimmunology |
| 001364 (1992) |
| Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
| 001365 (1992) |
| Vaccine comprising anti-idiotype antibody conjugate; induces production of neutralizing antibody (human monoclonal antibody, chimeric antibody or FAb, F(Ab′) 2 or Fv fragment) against HIV virus-1 |
| 001368 (1992) |
Murielle Godet [France] ; Rene L'Haridon [France] ; Jean-Francois Vautherot [France] ; Hubert Laude [France] | TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions |
| 001370 (1992) |
| Recombinant pox virus containing Morbilli virus DNA; expression of e.g. measles virus haemagglutinin glycoprotein in host for construction of a potential recombinant vaccine against dog distemper virus |
| 001371 (1992) |
| Recombinant feline corona virus-S protein; expressed as galactokinase fusion protein and useful as reconbinant vaccine, therapeutic and diagnostic agents for feline-infectious-peritonitis virus |
| 001374 (1992) |
| Nucleic acid constructs, malaria polypeptides and vaccines; recombinant malaria serine-repeat antigen production in yeast for the construction of a recombinant vaccine |
| 001375 (1992) |
| New gene fragment encoding rabies virus glycoprotein; DNA sequence expression in eukaryote cell culture and application to recombinant vaccine construction |
| 001378 (1992) |
| Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast |
| 001386 (1992) |
| Antigen composition comprising PEB1 and/or PEB3 antigen from Campylobacter jejuni ; useful as vaccine and for diagnosis of C. jejuni and Campylobacter coli infections |
| 001477 (1989) |
| Synthetic peptide antigen corresponding to the major sites of T-lymphocyte recognition within the HIV virus envelope protein: recombinant vaccine production |
| 001478 (1989) |
| Peptide capable of binding rubella immunoglobulin useful for rubella diagnosis and vaccine production; expression in Escherichia coli |
| 001479 (1989) |
| Parasitic nematode vaccine for human and animal protection fusion protein expression |
